Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Goy

Showing results (21-30 of 164) with videos related to

Pageof 17
Sort By:
Journal for Immunotherapy of Cancer|April 13, 2021
Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemiaG Doug Myers, Michael R Verneris, Andre Goy, et al.
The Journal of Liquid Biopsy|March 3, 2025
Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic CNS tumorsAhmad Charifa, Sally Agersborg, Arash Mohtashamian, et al.
The Journal of Liquid Biopsy|March 3, 2025
Expanding the clinical utility of liquid biopsy by using liquid transcriptome and artificial intelligenceMaher Albitar, Ahmad Charifa, Sally Agersborg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2006
Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphomaAnas Younes, Luis Fayad, Jorge Romaguera, et al.
Journal of Tissue Engineering|November 11, 2011
Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell MixturesCarlos E Caicedo-Carvajal, Qing Liu, Yvonne Remache, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Survivin expression predicts poorer prognosis in anaplastic large-cell lymphomaEllen J Schlette, L Jeffrey Medeiros, Andre Goy, et al.
Cancer Treatment Reviews|March 17, 2004
Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issuesDaniel H Silverman, Ebrahim S Delpassand, Farzad Torabi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 22, 2019
To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphomaPeter Martin, Andre Goy, Radhakrishnan Ramchandren, et al.
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphomaAndrew Ip, Lindsay M Fogel, Bianca DeAgresta, et al.
Critical Reviews in Oncology/Hematology|April 2, 2013
The role of the ubiquitin proteasome system in lymphomaK Stephen Suh, Takemi Tanaka, Sreeja Sarojini, et al.
Pageof 17

Showing results (21-30 of 164) with videos related to

Sort By:
Pageof 17
Journal for Immunotherapy of Cancer|April 13, 2021
Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemiaG Doug Myers, Michael R Verneris, Andre Goy, et al.
The Journal of Liquid Biopsy|March 3, 2025
Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic CNS tumorsAhmad Charifa, Sally Agersborg, Arash Mohtashamian, et al.
The Journal of Liquid Biopsy|March 3, 2025
Expanding the clinical utility of liquid biopsy by using liquid transcriptome and artificial intelligenceMaher Albitar, Ahmad Charifa, Sally Agersborg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2006
Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphomaAnas Younes, Luis Fayad, Jorge Romaguera, et al.
Journal of Tissue Engineering|November 11, 2011
Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell MixturesCarlos E Caicedo-Carvajal, Qing Liu, Yvonne Remache, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Survivin expression predicts poorer prognosis in anaplastic large-cell lymphomaEllen J Schlette, L Jeffrey Medeiros, Andre Goy, et al.
Cancer Treatment Reviews|March 17, 2004
Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issuesDaniel H Silverman, Ebrahim S Delpassand, Farzad Torabi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 22, 2019
To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphomaPeter Martin, Andre Goy, Radhakrishnan Ramchandren, et al.
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphomaAndrew Ip, Lindsay M Fogel, Bianca DeAgresta, et al.
Critical Reviews in Oncology/Hematology|April 2, 2013
The role of the ubiquitin proteasome system in lymphomaK Stephen Suh, Takemi Tanaka, Sreeja Sarojini, et al.
Pageof 17